Curated Wealth Partners »

Heron Therapeutics shares owned by Curated Wealth Partners

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Curated Wealth Partners from 13F filings

Historical chart of Curated Wealth Partners investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Curated Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Curated Wealth Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $233k 2.5k 91.68

More positions owned by Curated Wealth Partners

S&p Global (SPGI)
Procter & Gamble Company (PG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Target Corporation (TGT)
Broadcom (AVGO)
Charles Schwab Corporation (SCHW)
Parker-Hannifin Corporation (PH)
Brightstar Lottery Shs Usd (BRSL)
Tesla Motors (TSLA)
Amphenol Corp Cl A (APH)
Cummins (CMI)
Packaging Corporation of America (PKG)
ResMed (RMD)
Abbott Laboratories (ABT)
Trane Technologies SHS (TT)

View all positions for Curated Wealth Partners

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
BlackRock
OrbiMed Advisors
Velan Capital Investment Management
Vanguard Capital Management
Millennium Management
Tejara Capital
Tang Capital Management
Palisade Capital Management
Congress Park Capital
Geode Capital Management
State Street Corporation
JW Asset Management
Pale Fire Capital SE

View all funds holding Heron Therapeutics